Stock Message Board http://investorshangout.com/search?q=AZNCF&am...mp;yt1=Go!
AstraZeneca Plc AZNCF Current Price and Quotes
Last Price 49.4567
Previous Close 49.4567 Open N/A
Daily Range N/A - N/A 52wk Range 53.55 - 44.60
Volume 0 Dividend N/A
Average Vol (3m) 1,778 Yield N/A
AstraZeneca Plc AZNCF
Company Information
15 Stanhope Gate
London W1K 1LN
United Kingdom
Phone: 44 (0)20-7304-5000
AstraZeneca Plc AZNCF
AstraZeneca Plc AZNCF
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Dec 31, 2012 20-F
CIK 0000901832
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: United Kingdom
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Not Available
Company Directors
Not Available
Company Notes
Formerly=Zeneca Group, PLC until 3-99
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
AstraZeneca Plc AZNCF
AZNCF Security Details Other Company Securities
Share Structure
Market Value1 $63,937,819,587 a/o Sep 06, 2013
Shares Outstanding 1,292,804,000 a/o Dec 23, 2011
Float Not Available
Authorized Shares Not Available
Par Value No Par Value
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
AZN - LSE - London Stock Exchange - Qualified
Short Selling Data
Short Interest 42,316 (-82.25%)
Aug 15, 2013
Significant Failures to Deliver No
Transfer Agent(s)
AstraZeneca Plc AZNCF Recent News
Sept 6, 2013 MicroCoal(tm) Appoints James Young, PhD, Past President of R&D for MedImmune Inc., as Chairman of th
Sept 6, 2013 MicroCoal(TM) Appoints James Young, PhD, Past President of R&D for MedImmune Inc., as Chairman of the Board
Sept 5, 2013 OTC Signal Daily Stock Watch - AstraZeneca PLC (NYSE: AZN)
Sept 2, 2013 Onglyza(R) (saxagliptin) Achieves Primary Safety Endpoint, Demonstrating No Increased Risk for Cardiovascular Death, Heart Attack or Stroke in SAVOR Cardiovascular Outcomes Trial
Aug 29, 2013 M&A Activities, Pending NDA Approvals, and Clinical Trial Results - Research Report on Sanofi, GSK, AstraZeneca, Keryx, and Rigel
Aug 14, 2013 Before the Bell Scans: GlaxoSmithKline PLC, Keryx Biopharma Inc., AstraZeneca PLC, and Raptor Pharma Corp.
Aug 14, 2013 Licenses, Phase III Trial Initiation and Results, and Investments - Research Report on Johnson & Johnson, Sanofi, AstraZeneca, Novartis, and GSK
Jul 31, 2013 New Sub-Analysis of PLATO ACS Study Suggests Patient Types and Stent Types Had No Impact on Findings of Reduced Rate of Stent Thrombosis With BRILINTA (ticagrelor)
Jul 26, 2013 U.S. FDA Acknowledges Receipt of Resubmission of the New Drug Application for Investigational Compound Dapagliflozin for the Treatment of Type 2 Diabetes
Jul 23, 2013 Drug Approvals, Study Results, and Clinical Collaborations for Top-Line Growth - Research Report on Pfizer, Merck & Co., Cubist, AstraZeneca and Impax
1
2
3
next >
AstraZeneca Plc AZNCF Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 27,973,000 33,591,000 33,269,000 32,804,000
Cost of Revenue 5,393,000 6,026,000 6,389,000 5,775,000
Gross Profit 22,580,000 27,565,000 26,880,000 27,029,000
Operating Expenses
Research and Development 5,243,000 5,523,000 5,318,000 4,409,000
Sales, General and Admin. 9,189,000 10,730,000 10,068,000 11,077,000
Non-Recurring Items - - - -
Other - - - -
Operating Income 8,148,000 12,795,000 11,494,000 11,543,000
Income From Continuing Operations
Add'l Income/Expense Items 528,000 2,035,000 516,000 (736,000)
Earnings Before Interest and Tax 8,676,000 13,347,000 12,010,000 10,807,000
Interest Expense 958,000 980,000 1,033,000 -
Earnings Before Tax 7,718,000 12,367,000 10,977,000 10,807,000
Income Tax 1,391,000 2,351,000 2,896,000 3,263,000
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 6,327,000 10,016,000 8,081,000 7,544,000
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 6,327,000 10,016,000 8,081,000 7,544,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 6,327,000 10,016,000 8,081,000 7,544,000
AZNCF AstraZeneca Plc Research DD Guide
AZNCF AstraZeneca Plc Stock Message Board http://investorshangout.com/search?q=AZNCF&am...mp;yt0=Go!
AZNCF AstraZeneca Plc Stock Quote http://www.otcmarkets.com/stock/AZNCF/quote
AZNCF AstraZeneca Plc Stock Chart http://www.otcmarkets.com/stock/AZNCF/chart
AZNCF AstraZeneca Plc Company Info http://www.otcmarkets.com/stock/AZNCF/company-info
AZNCF AstraZeneca Plc Recent News http://www.otcmarkets.com/stock/AZNCF/news
AZNCF AstraZeneca Plc Financials http://www.otcmarkets.com/stock/AZNCF/financials
AZNCF AstraZeneca Plc Filings and Disclosure http://www.otcmarkets.com/stock/AZNCF/filings
AZNCF AstraZeneca Plc Short Sales http://www.otcmarkets.com/stock/AZNCF/short-sales
AZNCF AstraZeneca Plc Insider Disclosure http://www.otcmarkets.com/stock/AZNCF/insider-transactions
AZNCF AstraZeneca Plc Research Reports http://www.otcmarkets.com/stock/AZNCF/research
AZNCF AstraZeneca Plc Summary http://finance.yahoo.com/q?s=AZNCF
AZNCF AstraZeneca Plc Historical Prices http://finance.yahoo.com/q/hp?s=AZNCF+Historical+Prices
AZNCF AstraZeneca Plc Interactive Chart http://finance.yahoo.com/echarts?s=AZNCF
AZNCF AstraZeneca Plc Basic Chart http://finance.yahoo.com/q/bc?s=AZNCF+Basic+Chart
AZNCF AstraZeneca Plc Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=AZNCF+Basic+Tech.+Analysis
AZNCF AstraZeneca Plc Headlines http://finance.yahoo.com/q/h?s=AZNCF+Headlines
AZNCF AstraZeneca Plc Press Releases http://finance.yahoo.com/q/p?s=AZNCF+Press+Releases
AZNCF AstraZeneca Plc Company Profile http://finance.yahoo.com/q/pr?s=AZNCF+Profile
AZNCF AstraZeneca Plc Key Statistics http://finance.yahoo.com/q/ks?s=AZNCF+Key+Statistics
AZNCF AstraZeneca Plc Industry http://finance.yahoo.com/q/in?s=AZNCF+Industry
AZNCF AstraZeneca Plc Major Holders http://finance.yahoo.com/q/mh?s=AZNCF+Major+Holders
AZNCF AstraZeneca Plc Insider Transactions http://finance.yahoo.com/q/it?s=AZNCF+Insider+Transactions
AZNCF AstraZeneca Plc Insider Roster http://finance.yahoo.com/q/ir?s=AZNCF+Insider+Roster
AZNCF AstraZeneca Plc Income Statement http://finance.yahoo.com/q/is?s=AZNCF
AZNCF AstraZeneca Plc Balance Sheet http://finance.yahoo.com/q/bs?s=AZNCF
AZNCF AstraZeneca Plc Cash Flow http://finance.yahoo.com/q/cf?s=AZNCF+Cash+Flow&annual
AZNCF AstraZeneca Plc Nasdaq http://www.nasdaq.com/symbol/AZNCF
AZNCF AstraZeneca Plc Market Watch http://www.marketwatch.com/investing/stock/AZNCF
AZNCF AstraZeneca Plc Bloomberg http://www.bloomberg.com/quote/AZNCF:US
AZNCF AstraZeneca Plc Morningstar http://quotes.morningstar.com/stock/s?t=AZNCF
AZNCF AstraZeneca Plc Bussinessweek http://investing.businessweek.com/research/st...cker=AZNCF
AZNCF AstraZeneca Plc Barchart http://www.barchart.com/quotes/stocks/AZNCF
AZNCF AstraZeneca Plc OTC Short Report http://otcshortreport.com/index.php?index=AZNCF
AZNCF AstraZeneca Plc Investopedia http://www.investopedia.com/markets/stocks/AZNCF/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC